Wow! ♥️

Checking in from #POLITICOHealthCare Summit. PPTA is here and ready to chat about plasma-derived medicines and their impact on EU priorities like strategic autonomy, supply chain resilience, critical medicine and more. #EUNeedsMorePlasma

Plasma-derived medicines are unique and different from chemically synthesised pharmaceuticals. 👇

It was wonderful to welcome Giles Platford, Chair of PPTA’s Global Executive Board, who stopped by the PPTA booth this morning at the #POLITICOHealthCare Summit. Great conversations all around!

No magic bullet for medicine shortages. 🌍💉 It’ll take a multi-modal approach. Join Giles Platford from PPTAEurope & Takeda for insights on plasma-derived therapies. x.com/i/broadcasts/1… #POLITICOHealthCare

A packed room at the #POLITICOHealthCare Summit heard Giles Platford, Chair of the PPTA Global Executive Board, speak about medicines shortages. He emphasised the need for flexible approaches & the value of inclusive dialogue. Stay tuned for more takeaways. #EUNeedsMorePlasma

Thank you to everyone at PPTAEurope, PPTA, and our member companies for making 2024 such a fantastic year. I hope each of you has a joyful and relaxing holiday season. I’m really looking forward to what exciting things 2025 will bring us. Happy holidays!

The process of manufacturing plasma-derived medicinal products (PDMPs) takes much longer to produce than chemically-synthesized pharmaceutical medicines. It may take up to 12 months to manufacture PDMPs, from the moment the donation is made until it is ready to be given to a

🎙️ Marilena Vrana, Vice President of Public Affairs and EU Operations was a guest on the latest episode of The Association Insights Podcast from OnWrd & UpWrd. In this episode, Marilena discusses PPTA advocacy work in Brussels, the importance of building trust with

You can also listen via: Apple Podcasts : podcasts.apple.com/us/podcast/lea… YouTube Podcasts: youtu.be/fEI9HR2YXKs Or on the web💻 : creators.spotify.com/pod/profile/th…

🔹IPOPI is organising a high-level Roundtable on respiratory infections and chronic respiratory disease in people with primary immunodeficiencies (PIDs). We will gather to kick off a reflection process on advancing care and policies in this critical area. 💡 The meeting will

Only a few weeks to go and spots are filling fast! Join us on 1 Oct in #Brussels to discuss the Critical Medicines Act. ✨ Keynote: Prof. Isabelle Meyts ✨ Moderator: Sarah-Taïssir Bencharif, MD سارة تيسير ✨ Expert panelists ✨ Networking reception Register now: forms.office.com/pages/response…

#ICYMI: The Plasma Protein Therapeutics Association welcomes the recognition of diversity across critical medicines in the draft report of MEP Tomislav Sokol on the Critical Medicines Act. The report’s recognition that not all medicines share the same supply chains paves the

We are inspired by the words of Marilena Vrana, who reminds us that plasma donors bring hope and stability to families every day ahead of #IPAW2025. plasmaweek.org/resources#cate… #PlasmaPowersPossibility

Our keynote speaker for the Critical Medicines Act event on 1 Oct is Professor Isabelle Meyts, a global leader in immunodeficiencies. She'll bring a patient-centered perspective to the discussion. Register today to join us in Brussels! forms.office.com/pages/response…

Less than 2 weeks to go until #IPAW2025 💛💙 We can’t wait to share the stories that show how #PlasmaPowersPossibility. Join us in filling feeds with IPAW’s colours and voices from the plasma community.  Download shareable graphics & tools. plasmaweek.org/resources#cate…

💉 International Plasma Awareness Week (IPAW, October 6–10) highlights how plasma donations save lives every day.​ ​ For people living with AATD, plasma donations aren’t a choice — they’re a lifeline.​ Each patient needs around 900 donations every year to receive their treatment.